Discover 568 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 568
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Location: Oklahoma City OK, Overland Park KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06465316
Phase1, Recruiting
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Oklahoma City OK, Richardson TX, Dallas TX,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT05646316
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
IV Ensure in Patients Receiving OPAT
for
Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates,
Location: Oklahoma City OK
Sponsor: IV Ensure
Sex: All
Age: 18+
Code: NCT06623318
Recruiting
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
for
Death; Neonatal, Morbidity;Newborn
Location: Oklahoma City OK, Ada OK, Elk City OK, Altus OK,
Sponsor: Mayo Clinic
Sex: All
Age: 0+
Code: NCT06087224
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Oklahoma City OK, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Oklahoma City OK, Dallas TX, Little Rock AR,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Oklahoma City OK, Overland Park KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase2, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Oklahoma City OK, Conroe TX, Houston TX, Sugar Land TX,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase2, Recruiting
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Oklahoma City OK, Dallas TX, Lubbock TX, Houston TX,
Sponsor: South Plains Oncology Consortium
Sex: All
Age: 1 - 20
Code: NCT02013336
Phase1, Recruiting
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
for
Acute Decompensated Heart Failure
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT02898181
Recruiting
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
for
Obesity in Pregnancy, Labor Complication
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Female
Age: 15 - 45
Code: NCT06488781
Phase2, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Oklahoma City OK, Houston TX, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase2, Recruiting
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness
for
Alcohol Misuse, Homeless
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18+
Code: NCT06821295
Phase2, Phase3, Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Oklahoma City OK, Dallas TX, Houston TX, San Antonio TX,